Drug intelligence / Profile preview

esomeprazole

Development stage
Approved
Lead developer
AstraZeneca
Modality
Small Molecules
Administration
Oral, Intravenous
01

Overview

Esomeprazole is a proton pump inhibitor (PPI) used to reduce stomach acid production. It is indicated for the treatment of gastroesophageal reflux disease (GERD), erosive esophagitis, duodenal and gastric ulcers, prevention of NSAID-associated gastric ulcers, eradication of *Helicobacter pylori* infection (in combination with antibiotics), and conditions involving excessive gastric acid such as Zollinger-Ellison syndrome. Esomeprazole works by specifically inhibiting the H+/K+-ATPase enzyme ("proton pump") in the gastric parietal cells, thereby blocking the final step in acid production. This inhibition is irreversible until new enzyme molecules are synthesized. The drug was developed by AstraZeneca.

Brand names
NexIUMNexIUM 24HRNexIUM24HRNexIUM-24HRNexIUM 24HR ClearminisNexIUM24HR ClearminisNexIUM-24HR ClearminisEsomeprazole Strontium
Other names
esomelone
02

Targets

ATP4A (Potassium–transporting ATPase alpha chain 1)

Beyond the preview

Go deeper on esomeprazole.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on esomeprazole.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call